GOLDMAN SACHS GROUP INC - OREXIGEN THERAPEUTICS INC ownership

OREXIGEN THERAPEUTICS INC's ticker is OREXXXXX and the CUSIP is 686164104. A total of 162 filers reported holding OREXIGEN THERAPEUTICS INC in Q1 2015. The put-call ratio across all filers is 1.86 and the average weighting 0.5%.

Quarter-by-quarter ownership
GOLDMAN SACHS GROUP INC ownership history of OREXIGEN THERAPEUTICS INC
ValueSharesWeighting
Q2 2016$182,000
-42.6%
422,161
-25.1%
0.00%
Q1 2016$317,000
-72.0%
563,503
-14.5%
0.00%
Q4 2015$1,133,000
-36.4%
658,727
-22.0%
0.00%
-100.0%
Q3 2015$1,782,000
-56.6%
844,741
+1.9%
0.00%0.0%
Q2 2015$4,103,000
+53.3%
828,951
+142.5%
0.00%0.0%
Q1 2015$2,677,000
-46.4%
341,890
-58.5%
0.00%0.0%
Q4 2014$4,992,000
-9.6%
823,694
-36.4%
0.00%0.0%
Q3 2014$5,520,000
+262.2%
1,295,887
+425.4%
0.00%
Q2 2014$1,524,000
+303.2%
246,647
+323.5%
0.00%
Q1 2014$378,000
-77.8%
58,242
-80.7%
0.00%
Q4 2013$1,702,000
-47.8%
302,270
-43.2%
0.00%
-100.0%
Q3 2013$3,260,000
+583.4%
531,846
+552.4%
0.00%
Q2 2013$477,000
-62.6%
81,527
-66.4%
0.00%
-100.0%
Q4 2012$1,274,000
-10.5%
242,680
-2.6%
0.00%0.0%
Q3 2012$1,423,000
+565.0%
249,056
+545.0%
0.00%
Q2 2012$214,000
-22.5%
38,612
-42.6%
0.00%
Q1 2012$276,00067,2770.00%
Other shareholders
OREXIGEN THERAPEUTICS INC shareholders Q1 2015
NameSharesValueWeighting ↓
Foresite Capital Management I, LLC 1,229,287$9,625,00044.28%
Foresite Capital Management II, LLC 4,200,047$32,886,00019.48%
Scale Management, LLC 2,884,305$22,584,00011.28%
Cheyne Capital Management (UK) LLP 1,484,409$11,601,0002.80%
Telemetry Investments, L.L.C. 463,039$3,626,0002.00%
NEA Management Company, LLC 3,709,000$29,041,0001.31%
Rock Springs Capital Management LP 1,550,000$12,137,0001.14%
Rhenman & Partners Asset Management AB 831,800$6,513,0001.10%
Tamarack Capital Management, LLC 1,000,000$7,830,0001.03%
RA Capital Management 1,186,229$9,288,0000.92%
View complete list of OREXIGEN THERAPEUTICS INC shareholders